How good are the current models of adrenocortical carcinoma for novel drug discovery?

Carmen Ruggiero; Mabrouka Doghman-Bouguerra; Enzo Lalli

doi:10.1080/17460441.2022.1993817

Journal Articles Expert Opinion on Drug Discovery Year : 2021

How good are the current models of adrenocortical carcinoma for novel drug discovery?

(1) , ,

1

Carmen Ruggiero

Function : Author
PersonId : 1122154

Institut de pharmacologie moléculaire et cellulaire

Mabrouka Doghman-Bouguerra

Function : Author
PersonId : 180670
IdHAL : mabrouka-doghman
ORCID : 0000-0001-5112-7755

Enzo Lalli

Function : Author
PersonId : 181343
IdHAL : enzo-lalli
ORCID : 0000-0002-0584-5681
IdRef : 179402625

Domains

Life Sciences [q-bio]

Fichier principal

EODC Ruggiero et al., 2021.pdf (90.39 Ko)

Origin : Files produced by the author(s)

Carmen Ruggiero : Connect in order to contact the contributor

https://hal-cnrs.archives-ouvertes.fr/hal-03538518

Submitted on : Friday, January 21, 2022-10:02:39 AM

Last modification on : Thursday, August 4, 2022-4:57:43 PM

Dates and versions

hal-03538518 , version 1 (21-01-2022)

Identifiers

HAL Id : hal-03538518 , version 1
DOI : 10.1080/17460441.2022.1993817

Cite

Carmen Ruggiero, Mabrouka Doghman-Bouguerra, Enzo Lalli. How good are the current models of adrenocortical carcinoma for novel drug discovery?. Expert Opinion on Drug Discovery, 2021, pp.1-3. ⟨10.1080/17460441.2022.1993817⟩. ⟨hal-03538518⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-COTEDAZUR SORBONNE-UNIVERSITE SU-SCIENCES

6 View

7 Download

How good are the current models of adrenocortical carcinoma for novel drug discovery?

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share